<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9865063</article-id><article-id pub-id-type="pmid">36675049</article-id><article-id pub-id-type="doi">10.3390/ijms24021517</article-id><article-id pub-id-type="publisher-id">ijms-24-01517</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Advances in Characterizing the Transport Systems of and Resistance to EntDD14, A Leaderless Two-Peptide Bacteriocin with Potent Inhibitory Activity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>P&#x000e9;rez-Ramos</surname><given-names>Adri&#x000e1;n</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-ijms-24-01517" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5084-2906</contrib-id><name><surname>Ladjouzi</surname><given-names>Rabia</given-names></name><xref rid="af1-ijms-24-01517" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4439-4251</contrib-id><name><surname>Mihasan</surname><given-names>Marius</given-names></name><xref rid="af2-ijms-24-01517" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Teiar</surname><given-names>Radja</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af1-ijms-24-01517" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9349-6807</contrib-id><name><surname>Benachour</surname><given-names>Abdellah</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af3-ijms-24-01517" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3113-1578</contrib-id><name><surname>Drider</surname><given-names>Djamel</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-ijms-24-01517" ref-type="aff">1</xref><xref rid="c1-ijms-24-01517" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Melino</surname><given-names>Sonia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-24-01517"><label>1</label>ICV-Institut Charles Viollette, UMR Transfrontali&#x000e8;re BioEcoAgro 1158, University Lille, INRAE, University Li&#x000e8;ge, UPJV, YNCREA, University Artois, University Littoral C&#x000f4;te d&#x02019;Opale, 59000 Lille, France</aff><aff id="af2-ijms-24-01517"><label>2</label>Biochemistry and Molecular Biology Laboratory, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Carol I Blvd, no. 20A, 700506 Iasi, Romania</aff><aff id="af3-ijms-24-01517"><label>3</label>U2RM-Stress and Virulence, UNICAEN, Esplanade de la Paix, 14000 Caen, France</aff><author-notes><corresp id="c1-ijms-24-01517"><label>*</label>Correspondence: <email>djamel.drider@univ-lille.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2023</year></pub-date><volume>24</volume><issue>2</issue><elocation-id>1517</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2022</year></date><date date-type="rev-recd"><day>06</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Enterocin DD14 (EntDD14) is a two-peptide leaderless bacteriocin produced by the <italic toggle="yes">Enterococcus faecalis</italic> 14 strain previously isolated from meconium. This bacteriocin is mainly active against Gram-positive bacteria. Leaderless bacteriocins do not undergo post-translational modifications and are therefore immediately active after their synthesis. As a result, the cells that produce such bacteriocins have developed means of protection against them which often involve transport systems. In this and our previous work, we constructed different mutants deleted in the genes involved in the transport functions, thus covering all the supposed components of this transport system, using <italic toggle="yes">Listeria innocua</italic> ATCC 33090 as the indicator strain to assess the activity of externalized EntDD14. We also assessed the self-resistance of the WT and all its engineered derivative mutants against EntDD14, provided extracellularly, in order to evaluate their self-resistance. The results obtained highlight that the ABC transporter constituted by the DdG, H, I, and J proteins contributes to EntDD14 export as well as resistance to an external supply of EntDD14. Our results also have established the essential role of the DdE and DdF proteins as primary transporters dedicated to the externalization of EntDD14. Moreover, the in silico data showed that DdE and DdF appear to assemble in a formation that forms an essential channel for the exit of EntDD14. This channel DdEF may interact with the ABC transporter DdGHIJ in order to control the flow of bacteriocin across the membrane, although the nature of this interaction remains to be elucidated.</p></abstract><kwd-group><kwd>enterocin DD14 (EntDD14)</kwd><kwd>ABC transporters</kwd><kwd>resistance to bacteriocins</kwd></kwd-group><funding-group><award-group><funding-source>la R&#x000e9;gion des Hauts-de-France</funding-source></award-group><funding-statement>This research was funded by la R&#x000e9;gion des Hauts-de-France, through ALIBIOTECH CPER/FEDER 2016/2021.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-24-01517"><title>1. Introduction</title><p>Bacteria compete with other microorganisms in their ecological niches for nutrients and other biotic and abiotic resources, and many have developed mechanisms enabling them to outcompete their rival congeners. One of these is the production of bacteriocins, which are ribosomally synthesized antimicrobial peptides [<xref rid="B1-ijms-24-01517" ref-type="bibr">1</xref>,<xref rid="B2-ijms-24-01517" ref-type="bibr">2</xref>,<xref rid="B3-ijms-24-01517" ref-type="bibr">3</xref>] produced by Gram-negative and Gram-positive bacteria, as well as by Archaea [<xref rid="B1-ijms-24-01517" ref-type="bibr">1</xref>,<xref rid="B4-ijms-24-01517" ref-type="bibr">4</xref>]. Bacteriocins produced by Gram-positive bacteria are currently the most studied, particularly the bacteriocins produced by lactic acid bacteria (designated as LAB-bacteriocins). Usually, LAB-bacteriocins possess narrow spectra and therefore are active against phylogenetically close bacteria. Nonetheless, some LAB-bacteriocins can target phylogenetically distant bacteria [<xref rid="B5-ijms-24-01517" ref-type="bibr">5</xref>].</p><p>Bacteriocins are synthesized as precursor peptides, in which the core peptide is preceded by an N-terminal leader peptide. These precursor peptides are known to be inactive and must be stripped of their leader peptide to produce the active form of the bacteriocin [<xref rid="B6-ijms-24-01517" ref-type="bibr">6</xref>]. Some of these bacteriocins can undergo enzymatic post-translational modifications (PTM), leading to post-translationally modified peptides (RiPPs) [<xref rid="B7-ijms-24-01517" ref-type="bibr">7</xref>]. Accordingly, bacteriocins can be classified into two main classes: class I, containing RiPPs; and class II, containing unmodified bacteriocins [<xref rid="B8-ijms-24-01517" ref-type="bibr">8</xref>]. These bacteriocins are low-molecular-weight (&#x0003c;10 kDa) thermostable peptides. There is also a third class of high-molecular-weight, thermolabile bacteriocins [<xref rid="B9-ijms-24-01517" ref-type="bibr">9</xref>,<xref rid="B10-ijms-24-01517" ref-type="bibr">10</xref>].</p><p>However, there is a relatively small number of bacteriocins that are synthesized without a leader peptide and are therefore active after their translation in the cytoplasm [<xref rid="B11-ijms-24-01517" ref-type="bibr">11</xref>]. These leaderless bacteriocins (LLB) were discovered by Cintas and co-workers following the characterization of an enterococcal bacteriocin named L50 [<xref rid="B12-ijms-24-01517" ref-type="bibr">12</xref>]. As can be predicted from the considerable number of genes constituting the genetic determinants of bacteriocins, their synthesis requires a mechanism involving modification, transport, and immunity proteins and in some cases additional accessory proteins [<xref rid="B13-ijms-24-01517" ref-type="bibr">13</xref>]. Genes coding for bacteriocins are generally organized as operons, located either on plasmids or in the chromosome, and their expressions are usually co-regulated [<xref rid="B13-ijms-24-01517" ref-type="bibr">13</xref>]. The transport of these bacteriocins is most often mediated by an ATP-binding cassette (ABC) transporter system [<xref rid="B14-ijms-24-01517" ref-type="bibr">14</xref>] and in some cases by a secretory pathway [<xref rid="B15-ijms-24-01517" ref-type="bibr">15</xref>]. The transport of leaderless bacteriocins is not yet fully understood. A first study conducted on aureocin 70 showed the involvement of an ABC type transporter named AurT, which is responsible of the externalization of the LLB aureocin A70 [<xref rid="B16-ijms-24-01517" ref-type="bibr">16</xref>], while NisT is the main transporter for nisin [<xref rid="B17-ijms-24-01517" ref-type="bibr">17</xref>]. The ABC transporter can help mature the bacteriocin by cleaving the leader peptide, or it may be carried out with the participation of an associated protein [<xref rid="B6-ijms-24-01517" ref-type="bibr">6</xref>,<xref rid="B14-ijms-24-01517" ref-type="bibr">14</xref>].</p><p>Bacteriocin-producing bacteria are protected against the toxicity of their own products by immunity mechanisms [<xref rid="B18-ijms-24-01517" ref-type="bibr">18</xref>]. Most of them, as well as many bacteriocin&#x02019;s mode of action, are not well understood. Nevertheless, some mechanisms have been characterized and can be mediated by specific proteins, such as that of the enterocin CRL35, where its immunity protein interacts with the forming pore, blocking it [<xref rid="B19-ijms-24-01517" ref-type="bibr">19</xref>] or that of nisin, where a NisI protein anchored to the extracellular membrane is able to hijack nisin molecules [<xref rid="B20-ijms-24-01517" ref-type="bibr">20</xref>]. Another mechanism involves the abovementioned ABC transporter that basically expels the surrounding bacteriocin across the membrane. This is the case of NisEFG for nisin [<xref rid="B21-ijms-24-01517" ref-type="bibr">21</xref>], or As-48EFGH for the cyclic enterocin AS-48 [<xref rid="B22-ijms-24-01517" ref-type="bibr">22</xref>].</p><p>EntDD14 is a leaderless bacteriocin composed of two highly related peptides [<xref rid="B23-ijms-24-01517" ref-type="bibr">23</xref>], which is produced by <italic toggle="yes">Enterococcus faecalis</italic> 14, a strain previously isolated from meconium [<xref rid="B24-ijms-24-01517" ref-type="bibr">24</xref>]. Recently, we have demonstrated that the EntDD14 transport system is mediated by an ABC transporter system [<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>] and, more importantly, by two proteins, DdE and DdF, carrying pleckstrin homology domains (PHb2) [<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>].</p><p>These findings related to EntDD14 transport were unexpected and suggested a mode of transport different from those described to date. To gain more insight on the EntDD14 transport systems, we compiled a collection of mutants of the genes which we assumed to have a role in the transport and assessed their activity against <italic toggle="yes">Listeria innocua</italic> as the indicator organism to evaluate the externalization of this bacteriocin by different combinations of transport systems.</p><p>In this work, we provide more information on the transport of EntDD14, through genetic evidence based on the construction of several mutant strains. We show that partial or total deletion of the ABC transport system does not completely abolish the transport and externalization of the bacteriocin to the extracellular medium. It is clear that the transport of the leaderless bacteriocin EntDD14 is strongly dependent on proteins DdE and DdF.</p></sec><sec sec-type="results" id="sec2-ijms-24-01517"><title>2. Results</title><sec id="sec2dot1-ijms-24-01517"><title>2.1. The EntDD14-ABC Transporter System Contains Four Proteins</title><p>The ABC transporter associated with EntDD14 synthesis was initially described as containing at least three genes corresponding to <italic toggle="yes">ddH</italic>, <italic toggle="yes">ddI</italic>, and <italic toggle="yes">ddJ</italic> genes [<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]. Deletion of the <italic toggle="yes">ddI</italic> gene significantly altered the transport of EntDD14, as the quantity of bacteriocin in the medium was reduced by ~75% [<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]. To determine the role of the other components of the EntDD14-ABC transporter system, different mutant strains were constructed, namely the &#x00394;ddG, the triple &#x00394;ddHIJ, and the quadruple &#x00394;ddGHIJ mutant strains, and assessed for their respective antibacterial activity against <italic toggle="yes">L. innocua</italic> ATCC 33090, used as a sensor and indicator strain. The total antibacterial activity obtained with the WT strain was used as the reference value for 100% of the activity (<xref rid="ijms-24-01517-f001" ref-type="fig">Figure 1</xref>). Thus, the culture from the triple &#x00394;ddHIJ or the quadruple &#x00394;ddGHIJ mutant strains showed an antibacterial activity of ~25% of the WT, similar to that obtained previously with the &#x00394;ddI mutant [<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]. The culture of the &#x00394;ddG mutant strain exhibited an antibacterial activity of ~33% (<xref rid="ijms-24-01517-f001" ref-type="fig">Figure 1</xref>). From this, it can be concluded that DdG, DdH, DdI, and DdJ form a functional assembly that is involved in up to 75% of EntDd14 enterocin transport.</p></sec><sec id="sec2dot2-ijms-24-01517"><title>2.2. The Proteins DdF and DdE Are Essential for the Transport of EntDD14</title><p>As described above, the ABC transporter system of EntDD14 in its totality is constituted by the four <italic toggle="yes">ddGHIJ</italic> genes (<xref rid="ijms-24-01517-f001" ref-type="fig">Figure 1</xref>) as has already been identified for the transport of other bacteriocins [<xref rid="B22-ijms-24-01517" ref-type="bibr">22</xref>,<xref rid="B27-ijms-24-01517" ref-type="bibr">27</xref>,<xref rid="B28-ijms-24-01517" ref-type="bibr">28</xref>]. These results suggest that the ABC transporter system is not the unique system involved in the transport of EntDD14. Therefore, partial or total deletion of the ABC transporter noticeably reduced but did not stop the transport of EntDD14 outside of the bacterial cell (<xref rid="ijms-24-01517-f001" ref-type="fig">Figure 1</xref>). This observation raises the question of what effect the loss of this bacteriocin transport activity could have. If the EntDD14 bacteriocin is not completely excreted into the extracellular medium, logically it must accumulate inside the producing cells where it could have a deleterious effect. Therefore, we assessed the survival of <italic toggle="yes">E. faecalis</italic> 14 and its isogenic mutant strains after 6 and 24 h of growth in GM17 (<xref rid="ijms-24-01517-f002" ref-type="fig">Figure 2</xref>).</p><p>After six hours of growth, no survival differences were observed between the WT and different mutant strains (<xref rid="ijms-24-01517-f002" ref-type="fig">Figure 2</xref>). The amount of EntDD14 produced after six hours of growth did not induce any cell toxicity. Nevertheless, after 24 h of growth, we could observe a loss of one log magnitude in in the &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutants&#x02019; survival rate (<xref rid="ijms-24-01517-f002" ref-type="fig">Figure 2</xref>) due to intracellular accumulation of EntDD14, strengthening the previously reported data [<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]. The &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutants do not exert any anti-<italic toggle="yes">Listeria</italic> activity, in spite of their intact ABC transport system. In these genetic backgrounds, EntDD14 appeared to be trapped in the producing cells, arguing that translocation of this bacteriocin can be performed only in the presence of DdE and DdF proteins.</p><p>All of these results support the essential role of the DdEF system in the transport of EntDD14. The DdEF system is likely a simple gradient-dependent transporter, which alone is unable to ensure the entire transport of EntDD14 in the WT strain. The ABC transporter composed of DdGHIJ is an active ATP-dependent transporter, boosting the DdEF system to fully expel the bacteriocin outside the cell against a gradient concentration. These independent systems are thought to interact synergistically in the transport of EntDD14 outside of the bacterial cell.</p></sec><sec id="sec2dot3-ijms-24-01517"><title>2.3. The ABC Transporter DdGHIJ Is Involved in the Resistance to Extracellular EntDD14</title><p>The different constructed mutants, as well as the WT strain, were tested against a pure solution of EntDD14 in order to determine their intrinsic resistance to this extracellularly added bacteriocin. The results obtained allowed us to define three distinct groups, as shown in <xref rid="ijms-24-01517-f003" ref-type="fig">Figure 3</xref>. In the first group, which involves the WT strain, &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutant strains clearly exhibited the highest MIC values against extracellular EntDD14, with values of up to 120 &#x000b5;g/mL. The second group, which contains &#x00394;<italic toggle="yes">ddG</italic>, &#x00394;<italic toggle="yes">ddI</italic>, &#x00394;<italic toggle="yes">ddHIJ</italic>, and &#x00394;<italic toggle="yes">ddGHIJ</italic> mutants of the ABC transporter system, is characterized by an intermediate resistance, with MIC values against extracellular EntDD14 of 80 &#x000b5;g/mL. Finally, the third group comprising the &#x00394;<italic toggle="yes">bac</italic> mutant, which is deficient in the synthesis of EntDD14 and the indicator strain <italic toggle="yes">L. innocua</italic> ATCC 33090, is characterized as having the lowest MIC values of 40 &#x000b5;g/mL (<xref rid="ijms-24-01517-f003" ref-type="fig">Figure 3</xref>).</p><p>To further analyze the interaction between the ABC transporter and the resistance to extracellular EntDD14, we performed growth kinetics in the presence of EntDD14 with a final concentration of 20 or 40 &#x000b5;g/mL. Notably, in the absence of added EntDD14, the growth of &#x00394;<italic toggle="yes">ddGHIJ</italic> was similar to that of the WT (<xref rid="ijms-24-01517-f004" ref-type="fig">Figure 4</xref>A). Remarkably, at 20 &#x000b5;g/mL of EntDD14, the quadruple &#x00394;<italic toggle="yes">ddGHIJ</italic> mutant showed an extended lag phase of five hours compared to the WT (<xref rid="ijms-24-01517-f004" ref-type="fig">Figure 4</xref>B), whereas at 40 &#x000b5;g/mL of EntDD14, the mutant was unable to grow (<xref rid="ijms-24-01517-f004" ref-type="fig">Figure 4</xref>C). These results support the hypothesis of the involvement of the ABC transporter in the detoxification of extracellular EntDD14.</p><p>The results in <xref rid="ijms-24-01517-f003" ref-type="fig">Figure 3</xref> show that the strains exhibiting the highest resistance to extracellular amounts of EntDD14 are the WT and the &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutants. These results are coherent for the WT because all its transport systems that regulate the EntDD14 accumulation levels are compatible with its development; however, this is not the case for the &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutants. Indeed, these mutants are deficient in DdE or DdF proteins, indicating that the transport system comprising both proteins plays no role in the resistance to the extracellularly localized EntDD14. On the other hand, the resistance threshold of WT, &#x00394;<italic toggle="yes">ddE</italic>, and &#x00394;<italic toggle="yes">ddF</italic> mutants does not differ much from those obtained in mutants related to the ABC transporter (~2-fold) or the <italic toggle="yes">Listeria</italic> control strain (~3-fold). This can be explained by an unspecific effect of the bacteriocin when applied at a high concentration, causing a detergent-like effect, which has been reported for some cationic peptides [<xref rid="B29-ijms-24-01517" ref-type="bibr">29</xref>].</p><p>The results in <xref rid="ijms-24-01517-f004" ref-type="fig">Figure 4</xref> are also consistent with the ABC transport system, which is involved in resistance against EntDD14 by expelling it from the cellular membrane. This is reflected in panel B for which cells are confronted with EntDD14 extracellular concentrations (20 &#x000b5;g/mL) that cause problems in the fitness of the tested strains. Indeed, the WT takes about 10 h to adapt while the &#x00394;<italic toggle="yes">ddGHIJ</italic> mutant takes 5 h more; however, once the adaptation succeeds, the cells grow in almost the same way as in the absence of bacteriocin. In panel C, the EntDD14 extracellular concentrations (40 &#x000b5;g/mL) are beyond what the &#x00394;<italic toggle="yes">ddGHIJ</italic> mutant can tolerate, thus preventing it from growing; even the WT has its lag phase extended to 13 h for its adaptation and commencement of growth.</p></sec><sec id="sec2dot4-ijms-24-01517"><title>2.4. Predicted Structures of DdE, DdF, and DdE/DdF Show a Potential Transmembrane Channel</title><p>Both DdF and DdE have no homologs with known structures in the PDB database. Hence, Alphafold2, with its novel machine learning approach, was used to predict their structures. The best ranking structural model of DdF generated with a good confidence score (pLDDT value 78.3; maximum is 100) has the general aspect of a transmembrane channel with six mostly hydrophobic alpha-helices connecting the two predominantly hydrophilic regions on the extracellular and intracellular sides of the membrane. Viewed from the extracellular side, the helices are arranged in an incomplete circle (<xref rid="ijms-24-01517-f005" ref-type="fig">Figure 5</xref>) indicating that the channel is not complete. The DdE model was predicted to have a lower confidence score (pLDDT value 58.7) and consists of only two helices connecting the two predominantly hydrophilic regions. As both DdF and DdE are both independently required for the transport of EntDD14, we have attempted to model a multimeric complex using various subunit stoichiometries: DdE/DdF; (DdE)2/DdF; (DdE)3/DdF; DdE/(DdF)2; and (DdE)2/(DdF)2. A structural model with the highest confidence score (iptm + ptm value of 0.7; maximum is 1) was obtained for the DdE/DdF complex (<xref rid="ijms-24-01517-f005" ref-type="fig">Figure 5</xref>). In the complex, DdE and DdF hydrophobic helices are arranged in a complete circle, which looks like a functional transmembrane channel in agreement with the previous results stating that these proteins are involved in the exit and entry of EntDD14. Moreover, this formation associating the two proteins, DdE and DdF, also explains the fact that when one of them is missing, the translocation process across the plasma membrane no longer takes place.</p></sec></sec><sec sec-type="discussion" id="sec3-ijms-24-01517"><title>3. Discussion</title><p>The transport of bacteriocins from the cytoplasm to the extracellular environment is a complex process usually involving Gram-positive bacteria in the ATP-binding cassette (ABC) transport system, which consists of multidomain membrane proteins powered by the energy from ATP binding and hydrolysis to expel bacteriocins across the membrane hydrophobic barrier [<xref rid="B30-ijms-24-01517" ref-type="bibr">30</xref>]. In addition to the transport of bacteriocins and peptides involved in quorum sensing, the ABC transport system may have a role in resistance to bacteriocins such as nisin and bacitracin [<xref rid="B31-ijms-24-01517" ref-type="bibr">31</xref>].</p><p>ABC transporters form one of the largest families of membrane proteins are present in different life lineages. They are able to transport small ions as well as large proteins [<xref rid="B32-ijms-24-01517" ref-type="bibr">32</xref>]. Notably, ABC transporters can serve for outward or inward flows [<xref rid="B33-ijms-24-01517" ref-type="bibr">33</xref>]. The proteins of the ABC transport system consist of four domains, of which two are hydrophobic transmembrane domains (TMD), which bind and transport the substrates, and two hydrophilic cytosolic nucleotide-binding domains (NBD), which are the site of ATP binding and hydrolysis [<xref rid="B14-ijms-24-01517" ref-type="bibr">14</xref>].</p><p>The ABC transporter system is not the only system in Gram-positive bacteria to transport bacteriocins. Indeed, a number of class II bacteriocins, such as bacteriocin 31, enterocin P, bacteriocin T8, divergicin A, and lactococcin 972, can be secreted across cell membranes through the <italic toggle="yes">Sec</italic>-dependent pathway [<xref rid="B6-ijms-24-01517" ref-type="bibr">6</xref>].</p><p>It was reported that Gram-positive bacteria can predominantly use the ABC transporters to transport bacteriocins outside the cytoplasm, and in some cases, the Sec-dependent pathway [<xref rid="B6-ijms-24-01517" ref-type="bibr">6</xref>]. However, it would be interesting to know if there are bacteriocins capable of using both pathways. For the moment, this information is still lacking, although it has been reported in the case of bottromycin A2, which is a RiPP containing macrocyclic amidine and unusual &#x003b2;-methylated amino acid residues [<xref rid="B34-ijms-24-01517" ref-type="bibr">34</xref>].</p><p>In the case of the two-peptide leaderless EntDD14, genes encoding the ABC transporters are included in a cluster of 10 genes. Genes <italic toggle="yes">ddG</italic>, <italic toggle="yes">ddH</italic>, <italic toggle="yes">ddI</italic>, and <italic toggle="yes">ddJ</italic> are most likely encoding the components of the ABC transporters involved in the transport of EntDD14. While the role of DdG encoded by the <italic toggle="yes">ddG</italic> gene remains to be determined, the other genes code for well-known products. The gene <italic toggle="yes">ddH</italic> encodes a putative efflux Resistance-nodulation-division (RND) transporter periplasmic adaptor subunit, and <italic toggle="yes">ddI</italic> and <italic toggle="yes">ddJ</italic> genes encode an ATP-binding protein of the ATPase family and a putative macrolide export ATP-binding/permease protein (MacB), respectively. Bioinformatic analyses underpinned a high percentage of identity between DdHIJ and FGH proteins, which are part of the enterocin As-48-ABC transporters. The percentages of identity were 94%, 98%, and 98%, respectively. However, the identity between DdG and E protein, which represents its counterpart from As-48, was found to be ~46%.</p><p>In respect to EntDD14, it has become evident that the ABC transporter is not the only actor taking this role. Indeed, partial or total deletion of the ABC transporter system does not abolish the transport of EntDD14 outside of the cytoplasm, arguing that another pathway independent of the ABC system is involved. This independent pathway may imply DdE and DdF pleckstrin homology domain-containing proteins that may form potential channels, as discussed above and previously reported [<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]. In related to this, recently we established that <italic toggle="yes">E. faecalis</italic> 14, deficient in proteins DdE and DdF, is unable to transport EntDD14 into the extracellular medium, as the bacteriocin was not detected in the &#x00394;<italic toggle="yes">ddE</italic> and &#x00394;<italic toggle="yes">ddF</italic> mutant supernatant cultures. On the contrary, EntDD14 is accumulated intracellularly, exerting a toxic effect. From these data, we can conclude that there is a potential interrelationship between the two systems: the ABC transporter DdGHIJ and the novel pathway composed of DdE and DdF proteins. Such an independent but interacting system has already been reported in other leaderless bacteriocins such as aureocin A53, in which Orf7 and Orf8, which are homologous to DdE and DdF, are involved in the transport of this bacteriocin [<xref rid="B27-ijms-24-01517" ref-type="bibr">27</xref>]. It should be pointed out that, in the case of aureocin, the alteration of the ABC transporters decreased the transport of this bacteriocin [<xref rid="B27-ijms-24-01517" ref-type="bibr">27</xref>]. Thus, in both systems, it is clear that the ABC transporters are unable to transport the newly formed bacteriocins in the absence of DdE and DdF in the case of EntDD14, or their counterparts Orf7 and Orf8 in the case of aureocin A53. Further studies are required to decrypt the interplay between both systems and their dependence or lack thereof on the energy from ATP hydrolysis.</p><p>In respect to the contributions of the EntDD14 transporters, either the ABC machinery, which is composed of DdG, DdH, DdI, and DdJ proteins, or the novel likely channel pathway composed of proteins DdE, DdF, or DdEF with resistance to extracellular EntDD14, we show here that ABC transporter DdGHIJ plays a role with intermediate profile, but DdEF does not. Interestingly, ABC transporters of As-48, which are named AS-48EFGH, also confer resistance to this bacteriocin, when it is added extracellularly [<xref rid="B22-ijms-24-01517" ref-type="bibr">22</xref>].</p><p>In the present work, we strengthen the former hypothesis in which the ABC transporter DdGHIJ is not the unique molecular actor involved in the transport of EntDD14. Indeed, using the triple and quadruple mutant strains constructed here (&#x00394;<italic toggle="yes">ddHIJ</italic> and &#x00394;<italic toggle="yes">ddGHIJ</italic>), we established that the production of EntDD14 is not fully completed, as it is in the WT strain, in spite of the expression of genes encoding this bacteriocin. An independent system constituted of DdE and DdF proteins associated in the form of a protein complex whose organizational conformation reveals a channel that can serve as an exit route for the EntDD14 is absolutely and definitely required. On the other hand, we established that the ABC transporter involved in the translocation of EntDD14 has a role in the resistance to this bacteriocin.</p><p>The phenotypic results of the mutants obtained throughout these works support the following hypothesis. To transport EntDD14 outside the cell, the bacterium uses the DdEF channel as a primary non-ATP-dependent transport up to a certain concentration of EntDD14 in the extracellular medium. After that, the bacterium will resort to the use of the ABC transporter composed of DdGHIJ which has to pump more bacteriocin into the extracellular medium. This ABC system requires ATP to transport the bacteriocin in the opposite direction of the concentration gradient. This ABC transporter is also involved in the protection of the bacterium against the bacteriocin accumulated outside the cell. This hypothesis would explain the fact that a <italic toggle="yes">ddGHIJ</italic> quadruple mutant continues to produce ~25% of the bacteriocin compared to the WT and the fact that DdE and/or DdF mutants are unable to externalize EntDD14. The two systems, DdEF and DdGHIJ, should operate synergistically to control the flow of bacteriocin across the membrane, through a mechanism that remains to be understood.</p></sec><sec id="sec4-ijms-24-01517"><title>4. Materials and Methods</title><sec id="sec4dot1-ijms-24-01517"><title>4.1. Bacterial Strains and Growth Conditions</title><p>All bacteria used in this work are listed in <xref rid="ijms-24-01517-t001" ref-type="table">Table 1</xref>. These microorganisms were routinely grown as following: <italic toggle="yes">Enterococcus faecalis</italic> strains in M17 medium supplemented with 0.5% glucose (GM17), at 37 &#x000b0;C. <italic toggle="yes">Escherichia coli</italic> strains in Luria&#x02013;Bertani (LB) broth at 37 &#x000b0;C by shaking at 160 rpm. The <italic toggle="yes">Listeria innocua</italic> ATCC 33090 strain in Brain Heart Infusion (BHI) broth at 37 &#x000b0;C. When bacteria carried the pLT06 plasmid or its derivatives, the medium was supplemented with chloramphenicol (Cm) at 10 &#x000b5;g/mL for <italic toggle="yes">E. coli</italic> or 15 &#x000b5;g/mL for <italic toggle="yes">E. faecalis</italic>.</p></sec><sec id="sec4dot2-ijms-24-01517"><title>4.2. Construction of the E. feacalis 14 Mutant Strains</title><p>The <italic toggle="yes">ddG</italic>, <italic toggle="yes">ddHIJ</italic>, and <italic toggle="yes">ddGHIJ</italic> genes were deleted from the <italic toggle="yes">E. faecalis</italic> 14 chromosomes by independent recombination events using the pLT06 plasmid [<xref rid="B35-ijms-24-01517" ref-type="bibr">35</xref>]. The oligonucleotides utilized in this work are listed in <xref rid="ijms-24-01517-t002" ref-type="table">Table 2</xref>. The full detailed protocol to achieve the construction of the mutants is provided in P&#x000e9;rez-Ramos et al. [<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]. Briefly, the flanking regions of each gene or gene cluster were cloned into the pLT06 plasmid after the subsequent steps of PCR amplification, restriction enzyme digestion, and ligation of the PCR and plasmid fragments. The constructions were performed in <italic toggle="yes">E. coli</italic> XL1-Blue strain and then, the generated recombinant plasmids were transferred by electroporation to the <italic toggle="yes">E. faecalis</italic> 14 WT strain or &#x00394;<italic toggle="yes">bac</italic> mutant strain as required. Afterward, the first recombinant event (the plasmid integration into the chromosome) in the cells was induced by shifting the growth temperature from 30 &#x000b0;C to 42 &#x000b0;C in the presence of Cm at 15 &#x000b5;g/mL. The positive colonies were subjected to the second recombinant event (plasmid excision from the chromosome) by culturing them in the absence of Cm at 30 &#x000b0;C. The suitable mutants for each gene or gene cluster deletions were verified by sequencing the surrounding genetic environment.</p></sec><sec id="sec4dot3-ijms-24-01517"><title>4.3. Antimicrobial Activity against the Indicator Strain L. innocua ATCC 33090</title><p>Overnight cultures from the WT and mutant strains, as well as purified EntDD14, were screened for their anti-<italic toggle="yes">L. innocua</italic> activity by using the spot-on-lawn s method. Briefly, a uniform layer of <italic toggle="yes">Listeria</italic> culture was deposited on a soft BHI agar (1%) plate using a swab. Then, we spot 4 &#x000b5;L of each culture of 2.10<sup>9</sup> CFU/mL on BHI agar previously inoculated with the target strain. Then, the plates were incubated at 4 &#x000b0;C for 1 h and then overnight at 37 &#x000b0;C. The absence or presence of inhibitory zones around the spots was recorded.</p></sec><sec id="sec4dot4-ijms-24-01517"><title>4.4. Purification of Bacteriocin</title><p>EntDD14 was purified from the supernatant of the WT. The purification procedure was adapted from Abriouel et al. [<xref rid="B36-ijms-24-01517" ref-type="bibr">36</xref>] and was performed as described in P&#x000e9;rez-Ramos et al. [<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]. Briefly, a 24 h cell-free supernatant and the CM Sephadex<sup>&#x000ae;</sup> C-25 resin (GE Healthcare Life Sciences, Chicago, IL, USA) were incubated together for 24 h at room temperature by shaking at 90 rpm. Then, using a chromatography column, the resin was settled and washed, first with distilled water and then with 0.5 M NaCl. The EntDD14 linked to the resin was eluted with 1.5 M NaCl. Afterwards, using PD MidiTrap G-10 columns (GE), the solution of EntDD14 was desalted with MilliQ water. The pure EntDD14 was then quantified with the BCA assay protein kit (Sigma-Aldrich, St. Louis, MO, USA) and dried out with the miVac Sample Concentrator (SP Scientific, Warminster, PA, USA) for storage. When used, an aliquot of pure EntDD14 was resuspended in the appropriate volume of MilliQ water to obtain the desired concentration.</p></sec><sec id="sec4dot5-ijms-24-01517"><title>4.5. Sensitivity of the WT and Engineered Variants to Extracellular EntDD14</title><p>The WT and all engineered variants were tested against their own bacteriocin provided extracellularly to evaluate their self-resistance. An exponential culture of each strain diluted to 10<sup>6</sup> CFU/mL was spread onto a M17 agar plate using a swab. 10 &#x000b5;L of a pure EntDD14 solution was deposited on the plate at different concentrations: 240, 200, 160, 120, 100, 80, 60, 40, and 20 &#x000b5;g/mL. The plates were incubated overnight at 37 &#x000b0;C and then the inhibition halos were measured. In addition, the bacterial growth of the <italic toggle="yes">E. faecalis</italic> 14 WT and its &#x00394;<italic toggle="yes">ddGHIJ</italic> mutant in a GM17 broth with and without the addition of EntDD14 at 20 or 40 &#x000b5;g/mL was monitored in a 96-well microplate using a SpectraMax i3 spectrophotometer (Molecular Devices, San Jose, CA, USA). The cultures were inoculated with overnight pre-cultures to achieve the same initial OD<sub>600nm</sub> of 0.2. Measurements were taken every 15 min at OD<sub>600nm</sub> for 19 h.</p></sec><sec id="sec4dot6-ijms-24-01517"><title>4.6. Alphafold2 Structure Prediction of DdE, DdF and DdE/DdF Complex</title><p>Models of DdE and DdF monomers were generated with AlphaFold2 [<xref rid="B37-ijms-24-01517" ref-type="bibr">37</xref>] running locally via Docker (<uri xlink:href="https://www.docker.com/">https://www.docker.com/</uri>, accessed on 15 March 2022) on an Ubuntu 20.04 workstation with the corresponding FASTA sequences (WP_086325714 and WP_086325715, respectively) as inputs and the full_dbs preset. Following AMBER99SB [<xref rid="B38-ijms-24-01517" ref-type="bibr">38</xref>] relaxation and OpenMM [<xref rid="B39-ijms-24-01517" ref-type="bibr">39</xref>] energy minimization, five models were generated, and the highest ranked conformation was selected based on its pLDDT confidence score. Assembly of a DdE/DdF multimeric complex at various stoichiometries was explored using AlphaFold2-Multimer [<xref rid="B40-ijms-24-01517" ref-type="bibr">40</xref>], and the Amber relaxed models were ranked based on their weighed combination of pTM and ipTM (iptm + ptm) confidence scores. Structures were visualized in UCSF ChimeraX [<xref rid="B41-ijms-24-01517" ref-type="bibr">41</xref>] and transmembrane topology was predicted using DeepTMHMM [<xref rid="B42-ijms-24-01517" ref-type="bibr">42</xref>].</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Steve W. Elson for their critical reading of the manuscript.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.P.-R., R.L., A.B. and D.D.; Investigation, A.P.-R., R.L., M.M. and R.T.; Data curation, A.P.-R.; Formal analysis, A.P.-R., R.L., M.M., A.B. and D.D.; Funding acquisition, D.D.; Supervision, D.D.; Writing&#x02014;original draft, A.P.-R.; Writing&#x02014;review and editing, A.P.-R., R.L., M.M., A.B. and D.D. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The <italic toggle="yes">E. faecalis</italic> 14 chromosome sequence is deposited on the NCBI database (accession number CP021161.1), as well as the DdE and DdF protein sequences (accession numbers WP_086325714 and WP_086325715, respectively).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-24-01517"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="editor">
<name><surname>Drider</surname><given-names>D.</given-names></name>
<name><surname>Rebuffat</surname><given-names>S.</given-names></name>
</person-group><source>Prokaryotic Antimicrobial Peptides: From Genes to Applications</source><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2011</year><isbn>978-1-4419-7691-8</isbn></element-citation></ref><ref id="B2-ijms-24-01517"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flaherty</surname><given-names>R.A.</given-names></name>
<name><surname>Freed</surname><given-names>S.D.</given-names></name>
<name><surname>Lee</surname><given-names>S.W.</given-names></name>
</person-group><article-title>The Wide World of Ribosomally Encoded Bacterial Peptides</article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1004221</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004221</pub-id><?supplied-pmid 25079075?><pub-id pub-id-type="pmid">25079075</pub-id></element-citation></ref><ref id="B3-ijms-24-01517"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meade</surname><given-names>E.</given-names></name>
<name><surname>Slattery</surname><given-names>M.A.</given-names></name>
<name><surname>Garvey</surname><given-names>M.</given-names></name>
</person-group><article-title>Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9010032</pub-id><?supplied-pmid 31963311?><pub-id pub-id-type="pmid">31963311</pub-id></element-citation></ref><ref id="B4-ijms-24-01517"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hammami</surname><given-names>R.</given-names></name>
<name><surname>Zouhir</surname><given-names>A.</given-names></name>
<name><surname>Le Lay</surname><given-names>C.</given-names></name>
<name><surname>Ben Hamida</surname><given-names>J.</given-names></name>
<name><surname>Fliss</surname><given-names>I.</given-names></name>
</person-group><article-title>BACTIBASE Second Release: A Database and Tool Platform for Bacteriocin Characterization</article-title><source>BMC Microbiol.</source><year>2010</year><volume>10</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-10-22</pub-id><?supplied-pmid 20105292?><pub-id pub-id-type="pmid">20105292</pub-id></element-citation></ref><ref id="B5-ijms-24-01517"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Todorov</surname><given-names>S.D.</given-names></name>
<name><surname>de Melo Franco</surname><given-names>B.D.G.</given-names></name>
<name><surname>Tagg</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Bacteriocins of Gram-Positive Bacteria Having Activity Spectra Extending beyond Closely-Related Species</article-title><source>Benef. Microbes</source><year>2019</year><volume>10</volume><fpage>315</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.3920/BM2018.0126</pub-id><pub-id pub-id-type="pmid">30773930</pub-id></element-citation></ref><ref id="B6-ijms-24-01517"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>S.</given-names></name>
<name><surname>Sonomoto</surname><given-names>K.</given-names></name>
</person-group><article-title>Diversified Transporters and Pathways for Bacteriocin Secretion in Gram-Positive Bacteria</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>4243</fpage><lpage>4253</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-8917-5</pub-id><pub-id pub-id-type="pmid">29560521</pub-id></element-citation></ref><ref id="B7-ijms-24-01517"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ortega</surname><given-names>M.A.</given-names></name>
<name><surname>van der Donk</surname><given-names>W.A.</given-names></name>
</person-group><article-title>New Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-Translationally Modified Peptide Natural Products</article-title><source>Cell Chem. Biol.</source><year>2016</year><volume>23</volume><fpage>31</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2015.11.012</pub-id><pub-id pub-id-type="pmid">26933734</pub-id></element-citation></ref><ref id="B8-ijms-24-01517"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soltani</surname><given-names>S.</given-names></name>
<name><surname>Hammami</surname><given-names>R.</given-names></name>
<name><surname>Cotter</surname><given-names>P.D.</given-names></name>
<name><surname>Rebuffat</surname><given-names>S.</given-names></name>
<name><surname>Said</surname><given-names>L.B.</given-names></name>
<name><surname>Gaudreau</surname><given-names>H.</given-names></name>
<name><surname>B&#x000e9;dard</surname><given-names>F.</given-names></name>
<name><surname>Biron</surname><given-names>E.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
<name><surname>Fliss</surname><given-names>I.</given-names></name>
</person-group><article-title>Bacteriocins as a New Generation of Antimicrobials: Toxicity Aspects and Regulations</article-title><source>FEMS Microbiol. Rev.</source><year>2021</year><volume>45</volume><fpage>fuaa039</fpage><pub-id pub-id-type="doi">10.1093/femsre/fuaa039</pub-id><pub-id pub-id-type="pmid">32876664</pub-id></element-citation></ref><ref id="B9-ijms-24-01517"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alvarez-Sieiro</surname><given-names>P.</given-names></name>
<name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>
<name><surname>Mu</surname><given-names>D.</given-names></name>
<name><surname>Kuipers</surname><given-names>O.P.</given-names></name>
</person-group><article-title>Bacteriocins of Lactic Acid Bacteria: Extending the Family</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2016</year><volume>100</volume><fpage>2939</fpage><lpage>2951</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7343-9</pub-id><pub-id pub-id-type="pmid">26860942</pub-id></element-citation></ref><ref id="B10-ijms-24-01517"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Ramos</surname><given-names>A.</given-names></name>
<name><surname>Madi-Moussa</surname><given-names>D.</given-names></name>
<name><surname>Coucheney</surname><given-names>F.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
</person-group><article-title>Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>2107</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9102107</pub-id><pub-id pub-id-type="pmid">34683428</pub-id></element-citation></ref><ref id="B11-ijms-24-01517"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perez</surname><given-names>R.H.</given-names></name>
<name><surname>Zendo</surname><given-names>T.</given-names></name>
<name><surname>Sonomoto</surname><given-names>K.</given-names></name>
</person-group><article-title>Circular and Leaderless Bacteriocins: Biosynthesis, Mode of Action, Applications, and Prospects</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>2085</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02085</pub-id><pub-id pub-id-type="pmid">30233551</pub-id></element-citation></ref><ref id="B12-ijms-24-01517"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cintas</surname><given-names>L.M.</given-names></name>
<name><surname>Casaus</surname><given-names>P.</given-names></name>
<name><surname>Holo</surname><given-names>H.</given-names></name>
<name><surname>Hernandez</surname><given-names>P.E.</given-names></name>
<name><surname>Nes</surname><given-names>I.F.</given-names></name>
<name><surname>H&#x000e5;varstein</surname><given-names>L.S.</given-names></name>
</person-group><article-title>Enterocins L50A and L50B, Two Novel Bacteriocins from <italic toggle="yes">Enterococcus Faecium</italic> L50, Are Related to Staphylococcal Hemolysins</article-title><source>J. Bacteriol.</source><year>1998</year><volume>180</volume><fpage>1988</fpage><lpage>1994</lpage><pub-id pub-id-type="doi">10.1128/JB.180.8.1988-1994.1998</pub-id><pub-id pub-id-type="pmid">9555877</pub-id></element-citation></ref><ref id="B13-ijms-24-01517"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Drider</surname><given-names>D.</given-names></name>
<name><surname>Fimland</surname><given-names>G.</given-names></name>
<name><surname>H&#x000e9;chard</surname><given-names>Y.</given-names></name>
<name><surname>McMullen</surname><given-names>L.M.</given-names></name>
<name><surname>Pr&#x000e9;vost</surname><given-names>H.</given-names></name>
</person-group><article-title>The Continuing Story of Class IIa Bacteriocins</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2006</year><volume>70</volume><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00016-05</pub-id><pub-id pub-id-type="pmid">16760314</pub-id></element-citation></ref><ref id="B14-ijms-24-01517"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beis</surname><given-names>K.</given-names></name>
<name><surname>Rebuffat</surname><given-names>S.</given-names></name>
</person-group><article-title>Multifaceted ABC Transporters Associated to Microcin and Bacteriocin Export</article-title><source>Res. Microbiol.</source><year>2019</year><volume>170</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2019.07.002</pub-id><pub-id pub-id-type="pmid">31401108</pub-id></element-citation></ref><ref id="B15-ijms-24-01517"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cintas</surname><given-names>L.M.</given-names></name>
<name><surname>Casaus</surname><given-names>P.</given-names></name>
<name><surname>H&#x000e5;varstein</surname><given-names>L.S.</given-names></name>
<name><surname>Hern&#x000e1;ndez</surname><given-names>P.E.</given-names></name>
<name><surname>Nes</surname><given-names>I.F.</given-names></name>
</person-group><article-title>Biochemical and Genetic Characterization of Enterocin P, a Novel Sec-Dependent Bacteriocin from <italic toggle="yes">Enterococcus faecium</italic> P13 with a Broad Antimicrobial Spectrum</article-title><source>Appl. Environ. Microbiol.</source><year>1997</year><volume>63</volume><fpage>4321</fpage><lpage>4330</lpage><pub-id pub-id-type="doi">10.1128/aem.63.11.4321-4330.1997</pub-id><pub-id pub-id-type="pmid">9361419</pub-id></element-citation></ref><ref id="B16-ijms-24-01517"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Netz</surname><given-names>D.J.</given-names></name>
<name><surname>Sahl</surname><given-names>H.G.</given-names></name>
<name><surname>Marcelino</surname><given-names>R.</given-names></name>
<name><surname>dos Santos Nascimento</surname><given-names>J.</given-names></name>
<name><surname>de Oliveira</surname><given-names>S.S.</given-names></name>
<name><surname>Soares</surname><given-names>M.B.</given-names></name>
<name><surname>do Carmo de Freire Bastos</surname><given-names>M.</given-names></name>
<name><surname>Marcolino</surname><given-names>R.</given-names></name>
</person-group><article-title>Molecular Characterisation of Aureocin A70, a Multi-Peptide Bacteriocin Isolated from <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J. Mol. Biol.</source><year>2001</year><volume>311</volume><fpage>939</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1006/jmbi.2001.4885</pub-id><pub-id pub-id-type="pmid">11531330</pub-id></element-citation></ref><ref id="B17-ijms-24-01517"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lagedroste</surname><given-names>M.</given-names></name>
<name><surname>Reiners</surname><given-names>J.</given-names></name>
<name><surname>Smits</surname><given-names>S.H.J.</given-names></name>
<name><surname>Schmitt</surname><given-names>L.</given-names></name>
</person-group><article-title>Impact of the Nisin Modification Machinery on the Transport Kinetics of NisT</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>12295</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-69225-2</pub-id><pub-id pub-id-type="pmid">32703992</pub-id></element-citation></ref><ref id="B18-ijms-24-01517"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cotter</surname><given-names>P.D.</given-names></name>
<name><surname>Hill</surname><given-names>C.</given-names></name>
<name><surname>Ross</surname><given-names>R.P.</given-names></name>
</person-group><article-title>Bacteriocins: Developing Innate Immunity for Food</article-title><source>Nat. Rev. Microbiol.</source><year>2005</year><volume>3</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1273</pub-id><pub-id pub-id-type="pmid">16205711</pub-id></element-citation></ref><ref id="B19-ijms-24-01517"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barraza</surname><given-names>D.E.</given-names></name>
<name><surname>R&#x000ed;os Colombo</surname><given-names>N.S.</given-names></name>
<name><surname>Galv&#x000e1;n</surname><given-names>A.E.</given-names></name>
<name><surname>Acu&#x000f1;a</surname><given-names>L.</given-names></name>
<name><surname>Minahk</surname><given-names>C.J.</given-names></name>
<name><surname>Bellomio</surname><given-names>A.</given-names></name>
<name><surname>Chal&#x000f3;n</surname><given-names>M.C.</given-names></name>
</person-group><article-title>New Insights into Enterocin CRL35: Mechanism of Action and Immunity Revealed by Heterologous Expression in <italic toggle="yes">Escherichia coli</italic></article-title><source>Mol. Microbiol.</source><year>2017</year><volume>105</volume><fpage>922</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1111/mmi.13746</pub-id><pub-id pub-id-type="pmid">28692133</pub-id></element-citation></ref><ref id="B20-ijms-24-01517"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hacker</surname><given-names>C.</given-names></name>
<name><surname>Christ</surname><given-names>N.A.</given-names></name>
<name><surname>Duchardt-Ferner</surname><given-names>E.</given-names></name>
<name><surname>Korn</surname><given-names>S.</given-names></name>
<name><surname>G&#x000f6;bl</surname><given-names>C.</given-names></name>
<name><surname>Berninger</surname><given-names>L.</given-names></name>
<name><surname>D&#x000fc;sterhus</surname><given-names>S.</given-names></name>
<name><surname>Hellmich</surname><given-names>U.A.</given-names></name>
<name><surname>Madl</surname><given-names>T.</given-names></name>
<name><surname>K&#x000f6;tter</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>The Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin</article-title><source>J. Biol. Chem.</source><year>2015</year><volume>290</volume><fpage>28869</fpage><lpage>28886</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.679969</pub-id><pub-id pub-id-type="pmid">26459561</pub-id></element-citation></ref><ref id="B21-ijms-24-01517"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ra</surname><given-names>R.</given-names></name>
<name><surname>Beerthuyzen</surname><given-names>M.M.</given-names></name>
<name><surname>de Vos</surname><given-names>W.M.</given-names></name>
<name><surname>Saris</surname><given-names>P.E.J.</given-names></name>
<name><surname>Kuipers</surname><given-names>O.P.</given-names></name>
</person-group><article-title>Effects of Gene Disruptions in the Nisin Gene Cluster of <italic toggle="yes">Lactococcus lactis</italic> on Nisin Production and Producer Immunity</article-title><source>Microbiology</source><year>1999</year><volume>145</volume><issue-part>Pt 5</issue-part><fpage>1227</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1099/13500872-145-5-1227</pub-id><pub-id pub-id-type="pmid">10376839</pub-id></element-citation></ref><ref id="B22-ijms-24-01517"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diaz</surname><given-names>M.</given-names></name>
<name><surname>Valdivia</surname><given-names>E.</given-names></name>
<name><surname>Mart&#x000ed;nez-Bueno</surname><given-names>M.</given-names></name>
<name><surname>Fern&#x000e1;ndez</surname><given-names>M.</given-names></name>
<name><surname>Soler-Gonz&#x000e1;lez</surname><given-names>A.S.</given-names></name>
<name><surname>Ram&#x000ed;rez-Rodrigo</surname><given-names>H.</given-names></name>
<name><surname>Maqueda</surname><given-names>M.</given-names></name>
</person-group><article-title>Characterization of a New Operon, as-48EFGH, from the as-48 Gene Cluster Involved in Immunity to Enterocin AS-48</article-title><source>Appl. Environ. Microbiol.</source><year>2003</year><volume>69</volume><fpage>1229</fpage><lpage>1236</lpage><pub-id pub-id-type="doi">10.1128/AEM.69.2.1229-1236.2003</pub-id><?supplied-pmid 12571051?><pub-id pub-id-type="pmid">12571051</pub-id></element-citation></ref><ref id="B23-ijms-24-01517"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caly</surname><given-names>D.L.</given-names></name>
<name><surname>Chevalier</surname><given-names>M.</given-names></name>
<name><surname>Flahaut</surname><given-names>C.</given-names></name>
<name><surname>Cudennec</surname><given-names>B.</given-names></name>
<name><surname>Al Atya</surname><given-names>A.K.</given-names></name>
<name><surname>Chataign&#x000e9;</surname><given-names>G.</given-names></name>
<name><surname>D&#x02019;Inca</surname><given-names>R.</given-names></name>
<name><surname>Auclair</surname><given-names>E.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
</person-group><article-title>The Safe Enterocin DD14 Is a Leaderless Two-Peptide Bacteriocin with Anti-<italic toggle="yes">Clostridium perfringens</italic> Activity</article-title><source>Int. J. Antimicrob. Agents</source><year>2017</year><volume>49</volume><fpage>282</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2016.11.016</pub-id><?supplied-pmid 28104423?><pub-id pub-id-type="pmid">28104423</pub-id></element-citation></ref><ref id="B24-ijms-24-01517"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Al Atya</surname><given-names>A.K.</given-names></name>
<name><surname>Drider-Hadiouche</surname><given-names>K.</given-names></name>
<name><surname>Ravallec</surname><given-names>R.</given-names></name>
<name><surname>Silvain</surname><given-names>A.</given-names></name>
<name><surname>Vachee</surname><given-names>A.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
</person-group><article-title>Probiotic Potential of <italic toggle="yes">Enterococcus faecalis</italic> Strains Isolated from Meconium</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>227</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00227</pub-id><pub-id pub-id-type="pmid">25883590</pub-id></element-citation></ref><ref id="B25-ijms-24-01517"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ladjouzi</surname><given-names>R.</given-names></name>
<name><surname>Lucau-Danila</surname><given-names>A.</given-names></name>
<name><surname>Benachour</surname><given-names>A.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
</person-group><article-title>A Leaderless Two-Peptide Bacteriocin, Enterocin DD14, Is Involved in Its Own Self-Immunity: Evidence and Insights</article-title><source>Front. Bioeng. Biotechnol.</source><year>2020</year><volume>8</volume><fpage>644</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2020.00644</pub-id><?supplied-pmid 32671042?><pub-id pub-id-type="pmid">32671042</pub-id></element-citation></ref><ref id="B26-ijms-24-01517"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Ramos</surname><given-names>A.</given-names></name>
<name><surname>Ladjouzi</surname><given-names>R.</given-names></name>
<name><surname>Benachour</surname><given-names>A.</given-names></name>
<name><surname>Drider</surname><given-names>D.</given-names></name>
</person-group><article-title>Evidence for the Involvement of Pleckstrin Homology Domain-Containing Proteins in the Transport of Enterocin DD14 (EntDD14); a Leaderless Two-Peptide Bacteriocin</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>12877</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222312877</pub-id><pub-id pub-id-type="pmid">34884682</pub-id></element-citation></ref><ref id="B27-ijms-24-01517"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dos Santos Nascimento</surname><given-names>J.</given-names></name>
<name><surname>Coelho</surname><given-names>M.L.V.</given-names></name>
<name><surname>Ceotto</surname><given-names>H.</given-names></name>
<name><surname>Potter</surname><given-names>A.</given-names></name>
<name><surname>Fleming</surname><given-names>L.R.</given-names></name>
<name><surname>Salehian</surname><given-names>Z.</given-names></name>
<name><surname>Nes</surname><given-names>I.F.</given-names></name>
<name><surname>do Carmo de Freire Bastos</surname><given-names>M.</given-names></name>
</person-group><article-title>Genes Involved in Immunity to and Secretion of Aureocin A53, an Atypical Class II Bacteriocin Produced by <italic toggle="yes">Staphylococcus aureus</italic> A53</article-title><source>J. Bacteriol.</source><year>2012</year><volume>194</volume><fpage>875</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1128/JB.06203-11</pub-id><pub-id pub-id-type="pmid">22155775</pub-id></element-citation></ref><ref id="B28-ijms-24-01517"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iwatani</surname><given-names>S.</given-names></name>
<name><surname>Horikiri</surname><given-names>Y.</given-names></name>
<name><surname>Zendo</surname><given-names>T.</given-names></name>
<name><surname>Nakayama</surname><given-names>J.</given-names></name>
<name><surname>Sonomoto</surname><given-names>K.</given-names></name>
</person-group><article-title>Bifunctional Gene Cluster LnqBCDEF Mediates Bacteriocin Production and Immunity with Differential Genetic Requirements</article-title><source>Appl. Environ. Microbiol.</source><year>2013</year><volume>79</volume><fpage>2446</fpage><lpage>2449</lpage><pub-id pub-id-type="doi">10.1128/AEM.03783-12</pub-id><pub-id pub-id-type="pmid">23335763</pub-id></element-citation></ref><ref id="B29-ijms-24-01517"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rashid</surname><given-names>R.</given-names></name>
<name><surname>Veleba</surname><given-names>M.</given-names></name>
<name><surname>Kline</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides</article-title><source>Front. Cell Dev. Biol.</source><year>2016</year><volume>4</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.3389/fcell.2016.00055</pub-id><pub-id pub-id-type="pmid">27376064</pub-id></element-citation></ref><ref id="B30-ijms-24-01517"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rahman</surname><given-names>S.</given-names></name>
<name><surname>Mchaourab</surname><given-names>H.S.</given-names></name>
</person-group><article-title>ATP-Dependent Interactions of a Cargo Protein with the Transmembrane Domain of a Polypeptide Processing and Secretion ABC Transporter</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><fpage>14678</fpage><lpage>14685</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.014934</pub-id><pub-id pub-id-type="pmid">32820049</pub-id></element-citation></ref><ref id="B31-ijms-24-01517"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hiron</surname><given-names>A.</given-names></name>
<name><surname>Falord</surname><given-names>M.</given-names></name>
<name><surname>Valle</surname><given-names>J.</given-names></name>
<name><surname>D&#x000e9;barbouill&#x000e9;</surname><given-names>M.</given-names></name>
<name><surname>Msadek</surname><given-names>T.</given-names></name>
</person-group><article-title>Bacitracin and Nisin Resistance in <italic toggle="yes">Staphylococcus aureus</italic>: A Novel Pathway Involving the BraS/BraR Two-Component System (SA2417/SA2418) and Both the BraD/BraE and VraD/VraE ABC Transporters</article-title><source>Mol. Microbiol.</source><year>2011</year><volume>81</volume><fpage>602</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07735.x</pub-id><pub-id pub-id-type="pmid">21696458</pub-id></element-citation></ref><ref id="B32-ijms-24-01517"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hinsa</surname><given-names>S.M.</given-names></name>
<name><surname>Espinosa-Urgel</surname><given-names>M.</given-names></name>
<name><surname>Ramos</surname><given-names>J.L.</given-names></name>
<name><surname>O&#x02019;Toole</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Transition from Reversible to Irreversible Attachment during Biofilm Formation by <italic toggle="yes">Pseudomonas fluorescens</italic> WCS365 Requires an ABC Transporter and a Large Secreted Protein</article-title><source>Mol. Microbiol.</source><year>2003</year><volume>49</volume><fpage>905</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03615.x</pub-id><pub-id pub-id-type="pmid">12890017</pub-id></element-citation></ref><ref id="B33-ijms-24-01517"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davidson</surname><given-names>A.L.</given-names></name>
<name><surname>Dassa</surname><given-names>E.</given-names></name>
<name><surname>Orelle</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
</person-group><article-title>Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2008</year><volume>72</volume><fpage>317</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00031-07</pub-id><pub-id pub-id-type="pmid">18535149</pub-id></element-citation></ref><ref id="B34-ijms-24-01517"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shimamura</surname><given-names>H.</given-names></name>
<name><surname>Gouda</surname><given-names>H.</given-names></name>
<name><surname>Nagai</surname><given-names>K.</given-names></name>
<name><surname>Hirose</surname><given-names>T.</given-names></name>
<name><surname>Ichioka</surname><given-names>M.</given-names></name>
<name><surname>Furuya</surname><given-names>Y.</given-names></name>
<name><surname>Kobayashi</surname><given-names>Y.</given-names></name>
<name><surname>Hirono</surname><given-names>S.</given-names></name>
<name><surname>Sunazuka</surname><given-names>T.</given-names></name>
<name><surname>Omura</surname><given-names>S.</given-names></name>
</person-group><article-title>Structure Determination and Total Synthesis of Bottromycin A2: A Potent Antibiotic against MRSA and VRE</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2009</year><volume>48</volume><fpage>914</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1002/anie.200804138</pub-id><pub-id pub-id-type="pmid">19115340</pub-id></element-citation></ref><ref id="B35-ijms-24-01517"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thurlow</surname><given-names>L.R.</given-names></name>
<name><surname>Thomas</surname><given-names>V.C.</given-names></name>
<name><surname>Hancock</surname><given-names>L.E.</given-names></name>
</person-group><article-title>Capsular Polysaccharide Production in <italic toggle="yes">Enterococcus faecalis</italic> and Contribution of CpsF to Capsule Serospecificity</article-title><source>J. Bacteriol.</source><year>2009</year><volume>191</volume><fpage>6203</fpage><lpage>6210</lpage><pub-id pub-id-type="doi">10.1128/JB.00592-09</pub-id><pub-id pub-id-type="pmid">19684130</pub-id></element-citation></ref><ref id="B36-ijms-24-01517"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abriouel</surname><given-names>H.</given-names></name>
<name><surname>Valdivia</surname><given-names>E.</given-names></name>
<name><surname>Mart&#x000ed;nez-Bueno</surname><given-names>M.</given-names></name>
<name><surname>Maqueda</surname><given-names>M.</given-names></name>
<name><surname>G&#x000e1;lvez</surname><given-names>A.</given-names></name>
</person-group><article-title>A Simple Method for Semi-Preparative-Scale Production and Recovery of Enterocin AS-48 Derived from <italic toggle="yes">Enterococcus faecalis</italic> Subsp. <italic toggle="yes">liquefaciens</italic> A-48-32</article-title><source>J. Microbiol. Methods</source><year>2003</year><volume>55</volume><fpage>599</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/S0167-7012(03)00202-1</pub-id><pub-id pub-id-type="pmid">14607403</pub-id></element-citation></ref><ref id="B37-ijms-24-01517"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jumper</surname><given-names>J.</given-names></name>
<name><surname>Evans</surname><given-names>R.</given-names></name>
<name><surname>Pritzel</surname><given-names>A.</given-names></name>
<name><surname>Green</surname><given-names>T.</given-names></name>
<name><surname>Figurnov</surname><given-names>M.</given-names></name>
<name><surname>Ronneberger</surname><given-names>O.</given-names></name>
<name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></name>
<name><surname>Bates</surname><given-names>R.</given-names></name>
<name><surname>&#x0017d;&#x000ed;dek</surname><given-names>A.</given-names></name>
<name><surname>Potapenko</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Highly Accurate Protein Structure Prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="B38-ijms-24-01517"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hornak</surname><given-names>V.</given-names></name>
<name><surname>Abel</surname><given-names>R.</given-names></name>
<name><surname>Okur</surname><given-names>A.</given-names></name>
<name><surname>Strockbine</surname><given-names>B.</given-names></name>
<name><surname>Roitberg</surname><given-names>A.</given-names></name>
<name><surname>Simmerling</surname><given-names>C.</given-names></name>
</person-group><article-title>Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters</article-title><source>Proteins</source><year>2006</year><volume>65</volume><fpage>712</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1002/prot.21123</pub-id><pub-id pub-id-type="pmid">16981200</pub-id></element-citation></ref><ref id="B39-ijms-24-01517"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eastman</surname><given-names>P.</given-names></name>
<name><surname>Swails</surname><given-names>J.</given-names></name>
<name><surname>Chodera</surname><given-names>J.D.</given-names></name>
<name><surname>McGibbon</surname><given-names>R.T.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Beauchamp</surname><given-names>K.A.</given-names></name>
<name><surname>Wang</surname><given-names>L.-P.</given-names></name>
<name><surname>Simmonett</surname><given-names>A.C.</given-names></name>
<name><surname>Harrigan</surname><given-names>M.P.</given-names></name>
<name><surname>Stern</surname><given-names>C.D.</given-names></name>
<etal/>
</person-group><article-title>OpenMM 7: Rapid Development of High Performance Algorithms for Molecular Dynamics</article-title><source>PLoS Comput. Biol.</source><year>2017</year><volume>13</volume><elocation-id>e1005659</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005659</pub-id><pub-id pub-id-type="pmid">28746339</pub-id></element-citation></ref><ref id="B40-ijms-24-01517"><label>40.</label><element-citation publication-type="webpage"><comment>Available online: <ext-link xlink:href="https://www.biorxiv.org/content/10.1101/2021.10.04.463034v1" ext-link-type="uri">https://www.biorxiv.org/content/10.1101/2021.10.04.463034v1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-11-14">(accessed on 14 November 2022)</date-in-citation></element-citation></ref><ref id="B41-ijms-24-01517"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pettersen</surname><given-names>E.F.</given-names></name>
<name><surname>Goddard</surname><given-names>T.D.</given-names></name>
<name><surname>Huang</surname><given-names>C.C.</given-names></name>
<name><surname>Meng</surname><given-names>E.C.</given-names></name>
<name><surname>Couch</surname><given-names>G.S.</given-names></name>
<name><surname>Croll</surname><given-names>T.I.</given-names></name>
<name><surname>Morris</surname><given-names>J.H.</given-names></name>
<name><surname>Ferrin</surname><given-names>T.E.</given-names></name>
</person-group><article-title>UCSF ChimeraX: Structure Visualization for Researchers, Educators, and Developers</article-title><source>Protein Sci.</source><year>2021</year><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id><pub-id pub-id-type="pmid">32881101</pub-id></element-citation></ref><ref id="B42-ijms-24-01517"><label>42.</label><element-citation publication-type="webpage"><comment>Available online: <ext-link xlink:href="https://www.biorxiv.org/content/10.1101/2022.04.08.487609v1" ext-link-type="uri">https://www.biorxiv.org/content/10.1101/2022.04.08.487609v1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-11-14">(accessed on 14 November 2022)</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig position="float" id="ijms-24-01517-f001"><label>Figure 1</label><caption><p>Schematic representation of <italic toggle="yes">Enterococcus faecalis</italic> 14 mutants showing their genotypes and their antibacterial activities against <italic toggle="yes">Listeria innocua</italic> ATCC 33090. A volume of 4 &#x000b5;L in an overnight culture ~2 &#x000d7; 10<sup>9</sup> CFU/mL was spotted on the Brain Heart Infusion plate. The data are the means of at least three independent experiments.</p></caption><graphic xlink:href="ijms-24-01517-g001" position="float"/></fig><fig position="float" id="ijms-24-01517-f002"><label>Figure 2</label><caption><p>Survival of <italic toggle="yes">Enterococcus faecalis</italic> 14 and its mutant strains after 6 h and 24 h of growth in GM17. The data are the means of at least three independent experiments.</p></caption><graphic xlink:href="ijms-24-01517-g002" position="float"/></fig><fig position="float" id="ijms-24-01517-f003"><label>Figure 3</label><caption><p>Heatmap profile of <italic toggle="yes">Enterococcus faecalis</italic> 14 and its mutant strains in GM17 broth in the presence of extracellular EntDD14. The data are the means of at least three independent experiments.</p></caption><graphic xlink:href="ijms-24-01517-g003" position="float"/></fig><fig position="float" id="ijms-24-01517-f004"><label>Figure 4</label><caption><p>Growth curves of <italic toggle="yes">Enterococcus faecalis</italic> 14 and its &#x00394;<italic toggle="yes">ddGHIJ</italic> mutant strain in GM17 broth (<bold>A</bold>) and in the presence of EntDD14 at 20 &#x000b5;g/mL (<bold>B</bold>) and 40 &#x000b5;g/mL (<bold>C</bold>).</p></caption><graphic xlink:href="ijms-24-01517-g004" position="float"/></fig><fig position="float" id="ijms-24-01517-f005"><label>Figure 5</label><caption><p>Predicted structures of DdF and DdE and their possible assembly into the DdE/DdF complex, a potential complete transmembrane channel. Transmembrane topology as predicted using DeepTMHMM is highlighted in shades of blue for intracellular regions, shades of red for transmembrane regions, and shades of green for extracellular regions. Models were visualized with UCSF Chimera.</p></caption><graphic xlink:href="ijms-24-01517-g005" position="float"/></fig><table-wrap position="float" id="ijms-24-01517-t001"><object-id pub-id-type="pii">ijms-24-01517-t001_Table 1</object-id><label>Table 1</label><caption><p>List of the bacteria used in this work.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacteria</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plasmids</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL1-Blue</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasmid-free type strain used for plasmid cloning</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Agilent Technologies</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL1-Blue [plT06]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pLT06</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cm<sup>R</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Source of the conditioned replicative pLT06 plasmid used for mutant strategies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL1-Blue [pLT06:&#x00394;<italic toggle="yes">ddG</italic>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pLT06:&#x00394;<italic toggle="yes">ddG</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cm<sup>R</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Derivative of pLT06 by cloning of a 2158 pb DNA fragment harboring flanked regions of <italic toggle="yes">ddG</italic> gene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL1-Blue [pLT06:&#x00394;<italic toggle="yes">ddHIJ</italic>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pLT06:&#x00394;<italic toggle="yes">ddHIJ</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cm<sup>R</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Derivative of pLT06 by cloning of a 2052 pb DNA fragment harboring flanked regions of <italic toggle="yes">ddHIJ</italic> genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">XL1-Blue [pLT06:&#x00394;<italic toggle="yes">ddGHIJ</italic>]</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pLT06:&#x00394;<italic toggle="yes">ddGHIJ</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cm<sup>R</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Derivative of pLT06 by cloning of a 2134 pb DNA fragment harboring flanked regions of <italic toggle="yes">ddGHIJ</italic> genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Enterococcus faecalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Natural strain isolated from meconium</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-ijms-24-01517" ref-type="bibr">24</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">bac</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddAB</italic> genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddE</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddE</italic> gene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddF</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddF</italic> gene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-ijms-24-01517" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddG</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddG</italic> gene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddI</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddI</italic> gene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddHIJ</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddHIJ</italic> genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 &#x00394;<italic toggle="yes">ddGHIJ</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deletion mutant strain of <italic toggle="yes">ddGHIJ</italic> genes</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Listeria innocua</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 33090</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-ijms-24-01517" ref-type="bibr">25</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="ijms-24-01517-t002"><object-id pub-id-type="pii">ijms-24-01517-t002_Table 2</object-id><label>Table 2</label><caption><p>List of oligonucleotides used in this work.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Oligonucleotide</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence 3&#x02032;-5&#x02032;</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Utilization</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amplicon Size (pb)</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 1F-PstI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATTAAACTGCAGTTGAATTCACTCAATCATTTT</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Amplification of <italic toggle="yes">ddG</italic> upstream fragment</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">1.133</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 2R-Stop</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTATCACTAGGATCCTTAGACTTACTACGATACGTCTGTTTGTA</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 3F-Stop</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TAAGTCTAAGGATCCTAGTGATAGGATATAGGAGAAGATAATGAGT</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Amplification of <italic toggle="yes">ddG</italic> downstream fragment</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">1.049</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 4R-NcoI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATTAAACCATGGGAACACTGATTTGGACAT</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 5F</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGGAAAATGTTGATTTGGTGTTT</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Outer primer; verification of the plasmid integration</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddG 6R</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTAGAGATTGGGTTTGTTCTTCC</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 1F-PstI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATTAAACTGCAGAAATATGCTTTTTCCTTACA</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Amplification of <italic toggle="yes">ddHIJ</italic> upstream fragment</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">1.051</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 2R-Stop</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTATCACTAGGATCCTTAGACTTACTCATTATCTTCTCCTATATCT</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 3F-Stop</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TAAGTCTAAGGATCCTAGTGATAGGTAAAGGCCAAAGAATTAGA</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Amplification of <italic toggle="yes">ddHIJ</italic> downstream fragment</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">1.025</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 4R-NcoI</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATTAAACCATGGAATTTTATCCCAAAGAAAGT</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 5F</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCAGAATGTTTTCATGCGTT</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Outer primer; verification of the plasmid integration</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ddHIJ 6R</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AAGTTAATGGTGATACTTCACAA</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oriF</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAATAATCGCATCCGATTGCA</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Cloning verification in pLT06 plasmid</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ks05R</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCTATTATACCATATTTTGGAC</td></tr></tbody></table></table-wrap></floats-group></article>